For those interested in following biotechnology publishing trends, there is a useful resource in the September issue of Nature Biotechnology: Trends in biotech literature 2006. Andrew Marshall and Gaspar Taroncher-Oldenburg write: “unsurprisingly, microRNAs dominate the list of highest cited papers, and the area is witnessing rapid growth. The number of papers in other fields, such as proteomics, nanotech and RNA interference, also continues to expand; 80% of the publications specifically reporting cancer stem cells were published in the past two years. China and India continue to increase their output of biotech papers; France fell behind Spain and Italy; Switzerland entered the top 15 for the first time.” For futher details, see:
Number of biotechnology articles per region.
Historical trends in biotechnology fields.
Most cited institutions in pharmacology and toxicology.
(Gaspar Taroncher-Oldenburg is Editor of the Nature journals’ special pharmacology projects; Andrew Marshall is Chief Editor of Nature Biotechnology.)